Roche Holding AG said an experimental breast-cancer treatment will get an expedited review from US regulators after showing ...
Priority Review recognises the best-in-class potential of the inavolisib-based regimen for patients in urgent need of new ...
(RTTNews) - Swiss drug major Roche Holding AG (RHHBY) and its U.S. Unit Genentech announced Tuesday that the U.S. Food and Drug ...
LONDON (dpa-AFX) - Roche (RHHBY) said that it has received CE Mark approval for the VENTANA HER2 (4B5) Rabbit Monoclonal Primary Antibody RxDx, enabling the identification of metastatic breast ...
Roche-Aktie schwächelt: Boris Zaïtra ab Juli Pharma Partnering-Chef von Roche Neubesetzung Beim Pharmakonzern Roche kommt es am 1. Juli zu einem Wechsel in der erweiterten Konzernleitung.
Priority Review recognises the best-in-class potential of the inavolisib-based regimen for patients in urgent need of new treatment options 1,2 Additional analyses of INAVO120 will be presented in ...
Roche-Aktie für 0 € Ordergebühr (zzgl. Spreads) handeln – hier informieren ...